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Abstract
Adoptive cell transfer of Chimeric Antigen Receptor (CAR)-T cells showed promising results
in patients with B cell malignancies. However, the detailed mechanism of CAR-T cell inter-
action with the target tumor cells is still not well understood. This work provides a systematic
method for analyzing the activation and degranulation of second-generation CAR-T cells uti-
lizing antigen-presenting cell surfaces. Antigen-presenting cell surfaces composed of circu-
lar micropatterns of CAR-specific anti-idiotype antibodies have been developed to mimic the
interaction of CAR-T cells with target tumor cells using micro-contact printing. The levels of
activation and degranulation of fixed non-transduced T cells (NT), CD19.CAR-T cells, and
GD2.CAR-T cells on the antigen-presenting cell surfaces were quantified and compared by
measuring the intensity of the CD3ζ chain phosphorylation and the Lysosome-Associated
Membrane Protein 1 (LAMP-1), respectively. The size and morphology of the cells were
also measured. The intracellular Ca2+ flux of NT and CAR-T cells upon engagement with
the antigen-presenting cell surface was reported. Results suggest that NT and CD19.CAR-
T cells have comparable activation levels, while NT have higher degranulation levels than
CD19.CAR-T cells and GD2.CAR-T cells. The findings show that antigen-presenting cell
surfaces allow a quantitative analysis of the molecules involved in synapse formation in dif-
ferent CAR-T cells in a systematic, reproducible manner.
Introduction
Clinical trials with CAR-T cells redirected to target the pan-B cell antigen CD19 have shown
promising results in treating children and adults with B-cell acute lymphoblastic leukemia [1,
2]. In contrast, clinical trials with CAR-T cells in patients with solid tumors such as
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neuroblastoma, pancreatic cancer, and glioblastoma demonstrated limited success [3–5].
These discrepancies in clinical outcomes with CAR-T cells between liquid and solid tumors
call for a thorough understanding of how CAR-T cells interact with tumor cells [6]. In particu-
lar, understanding how CAR molecules expressed by T cells form immune synapses upon
engaging the antigen expressed by tumor cells may represent a significant steppingstone to
design better CAR-T cells.
In a recent report, Davenport et al. showed that the immune synapse formation of CAR-T
cells differs from its counterpart in non-transduced T cells engaging the antigen via the classic
T-cell-receptor (TCR) [7]. CAR-T-cells do not form the three concentric domains, known as
“bulls’ eye,” upon interacting with target cells. CAR-T cells lacked the aggregation of lck in the
central supramolecular activation cluster (cSMAC) and spent less time interacting with target
cells [8, 9]. Xiong et al. investigated the quality of the immune synapse formation in CAR-T
cells by quantifying F-actin, aggregation of tumor antigen, perforin polarization, and distribu-
tion of the phosphorylated CD3z chain [10]. The study showed that CAR-T cell effectiveness
correlates positively with the quality of the immune synapse formed.
Engineering micropatterned surfaces by microcontact printing are one effective way to
study the immune synapse formation in T cells. Micropatterned surfaces have been used in
immunological studies, as they can mimic micro-scale interactions in a cost and labor effective
manner. Microcontact printing allows for the isolation of molecules participating in the for-
mation of the immune synapse to understand their specific role better [11]. Doh and Irvine
developed immune synapse arrays carrying anti-CD3 monoclonal antibody (mAb) micropat-
terns and reproduced the formation of the “bull’s eye” [12]. Shen et al. used different orienta-
tions of anti-CD3 and anti-CD28 micropatterns to study the activation and cytokine secretion
of CD4+ T cells [13]. Tabdanov et al. used micropatterning to investigate the relationship
between the TCR and LFA-1 in regulating the cytoskeletal organization [14], while Motsch
et al. used micropatterning to quantify the interaction between TCR and Zap70 [15]. Here, we
develop a systematic method to study activation and degranulation in CAR-T cells using
micropatterned surfaces. We quantify the levels of activation and degranulation, the size and
morphology, and the intracellular Ca2+ flux of NT and CAR-T cells upon engagement with the
antigen-presenting cell surface. Results show that our proposed method can be a reliable one
to study CAR-T cells’ interaction with target antigens and can be easily extrapolated to study
other types of CAR-T cells.
Materials and methods
CAR-T cell preparation
As proof of concept, we have used CAR-T cells expressing either a CD19-specific CAR (CD19.
CAR-T cells) or a GD2-specific CAR (GD2.CAR-T cells) in which in both cases the CAR
encodes the CD28 costimulatory endodomain. CAR-T cells were generated as previously
described [16]. Briefly, human peripheral blood mononuclear cells (PBMC) were isolated
from discharged buffy coats (Gulf Coast Regional Blood Center, Houston, TX, US) and acti-
vated by plate-bound CD3 (1 ng/ml; Miltenyi Biotec, MA, US) and CD28 (1 ng/ml; BD Biosci-
ences, NJ, US) in media composed of 45% RPMI 1640, 45% Click’s Media (Irvine Scientific,
CA, US), 10% fetal bovine serum (Hyclone, PA, US), 1% L-glutamine (Invitrogen, CA, US),
IL-7 (10 ng/ml; Peprotech, NJ, US) and IL-15 (5 ng/ml; Peprotech, NJ, US). Stimulated
PBMCs were transduced with a g-retrovirus encoding the 2nd generation CD19 or GD2 CAR
on retronectin-coated plates (Takara Bio Inc, CA, US) and expanded for 10 days prior to anal-
ysis. The transduction efficiencies of CAR-T cells were analyzed at day or 12–14 of culture.
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Fabrication of antigen-presenting cell surfaces
The protocol for using microcontact printing to pattern proteins was previously described [13,
17, 18]. First, round coverslips (1.2 cm) (Fisher Scientific, NH, US) are washed with detergent
for 15 minutes at 110˚C. Coverslips are then sonicated in acid solution (50 mL dH2O, 2 mL
HNO3, 6 mL HCl) for 1 hour, rinsed thoroughly with deionized (DI) water, and stored in pure
ethanol. PDMS stamps with circular pillars (5 μm diameter x 5 μm spacing x 5 μm tall)
(Research Micro Stamps, SC, US) were incubated in 250–300 μL (50 μg/mL) of target antigen
overnight. To mimic the microscale contact of CAR-T cells with the antigen, we used the anti-
CD3 mAb for TCR activation and the anti-idiotype Abs 233-4A and 1A7 for CD19 CAR and
GD2 CAR activation, respectively. Following incubation, stamps were sequentially rinsed in
0.5% Tween-20 in PBS, PBS, and DI water, and dried with nitrogen gas. The coverslips are
removed from ethanol, dried with nitrogen gas, and treated with plasma for 3 minutes using
Harrick Plasma Cleaner (Harrick Plasma, NY, US) with plasma power set at high. Then,
stamps were immediately brought into contact with the plasma-treated coverslips for 5 min-
utes. Stamps were gently removed, and coverslips were washed with PBS to remove unbound
protein. Lastly, coverslips were incubated with 40 μL of recombinant human ICAM-1Fc chi-
mera protein (R&D Systems, MN, US) at a concentration of 2 μg/mL for 2 hours and rinsed
with PBS. Control coverslips were prepared by incubating 40 μL of recombinant human
ICAM-1Fc chimera protein (R&D Systems, MN, US) at a concentration of 2 μg/mL for 2
hours. Control coverslips and coverslips with micropatterns were placed in a 24-well plate for
cells to be deposited on them. For live imaging studies, micropatterns were visualized by pre-
labeling with Alexa Fluor 568 antibody labeling kit (Thermofisher Scientific, MA, US) follow-
ing the manufacturer’s protocol.
T cell interaction with antigen-presenting cell surface
Cryopreserved cells were thawed and cultured in complete medium (1:1 ratio of RPMI-1640
(GE Healthcare Bio-Sciences, PA, US) and Click’s medium (IrvineScientific, CA, US) contain-
ing 10% FBS (Atlanta Biologicals, GA, US), 1% glutamine (Hyclone Laboratories, PA, US), 1%
P/S (Hyclone Laboratories, PA, US), 10 ng/mL IL-7 (PeproTech, NJ, US), and 5 ng/mL IL-15
(PeproTech, NJ, US) at 37˚C and 5% CO2 for 5 days. On day 5, cells were counted, normalized
for transduction efficiency, and resuspended in a fresh, complete medium. Cells were seeded
to the 24-well plate at a density of 1.5x105 cells/well. Samples were incubated at 37˚C and 5%
CO2 for 30 minutes for NT and 10 minutes for CAR-T cells. Half of the media volume was
carefully removed from each well, and 525 μL of 4% PFA in PBS (Thermofisher Scientific,
MA, US) was gently added to the side of each well. Cells were incubated for 15 minutes, then
350 μL of liquid was removed, and 1.05 mL of permeabilization buffer (0.1% Triton X-100 in
PBS) was added. Cells were incubated for another 10 minutes, then washed three times with
500 μL of PBS (5 min/wash on a rocker). PBS was removed, and 500 μL of blocking solution
(4% BSA (Sigma Aldrich, MO, US) in PBS) was added to each well. Cells were incubated for
1–2 hours in blocking solution followed by washing and incubation with 350 μL of goat anti-
mouse Alexa Fluor (AF) 568 secondary Ab (2 μg/mL) for 30 minutes to label the micropat-
terns. Cells were washed five times with PBS, then incubated with 350 μL of primary Ab (8 μg/
mL p-CD3z-AF488, 8 μg/mL CD107a-AF405 in blocking solution) for 1 hour to label the
phosphorylated -CD3z chain (p-CD3z) and the LAMP1/CD107a, respectively. Cells were
washed three times with PBS and incubated with 500 μL of 4% PFA in PBS for 10 minutes.
Finally, fixed samples were washed three times with PBS, mounted onto glass slides using Vec-
tashield mounting medium (Vector Laboratories, CA, US), and visualized.
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Fluorescence imaging and analysis
Round coverslips mounted on glass slides were imaged using ZEISS LSM 710 two-photon con-
focal microscope (Carl Zeiss Microscopy, LLC, NY, US) and Zen 2.0 software. Images were
acquired at 20x magnification (NA 0.8) air and (1024 x 1024 (425.1 μm × 425.1 μm)) resolution
through consecutive scans of Brightfield, AF 405 (excitation 405 nm; 1 AU pinhole aperture),
AF 488 (excitation 488 nm; 1 AU pinhole aperture), and AF 568 (excitation 561 nm; 1 AU pin-
hole aperture). For each sample, at least two field of views were randomly selected and imaged
at the plane just above the micropattern. A minimum of 60 cells was imaged from each sample.
Acquired images were analyzed using ImageJ following previously published protocols [19–
22]. Cells were outlined manually, and the integrated density of each cell outline and its adja-
cent non-fluorescent area was measured across all channels using the “analyze/measure” com-
mand. Measurements of non-fluorescent regions were used as background measurements and
were subtracted from the integrated density of the cell outline. Hence, the corrected total cell
fluorescence (CTCF) was calculated using the following equation:
CTCF ¼ Integrated densitycell outline   ðAreacell outline �MeanbackgroundÞ ð1Þ
By subtracting the area and the mean fluorescence of the surrounding regions, Eq (1) mitigates
both the effect of cell size and background on the integrated density of the cell outline. The dis-
tribution of p-CD3z and LAMP1 was measured using the integrated density of cells because
the integrated density can capture the dim and the bright regions in the cell outline compared
to measuring the mean [19–22].
Measurement of cell morphology. Cell morphology was quantitatively measured using
the circularity measurement in ImageJ. Circularity is a shape descriptor with values ranging
from zero to one. A circularity value of 1 represents a perfect circle, while a value less than 1
represents more elongated shapes with 0 representing a perfect ellipse. The “Threshold” and
“Analyze Particles” commands in ImageJ were used to quantify the morphology of cells. For








For live cell imaging, cells were labeled with Fluo-4, AM, cell-permeant kit (Thermofisher Sci-
entific, MA, US). Cells were loaded with Fluo-4, AM, according to the manufacturer’s proto-
col. Briefly, a solution of 1mM of Fluo-4-AM was prepared by dissolving 50 μg of Fluo-4 AM
in 45.6 μL DMSO. The solution was vortexed for 1 minute, sonicated for 1 minute, and centri-
fuged for 1 minute. The concentration of the solution was halved by adding 20% Pluronic F-
127 DMSO. Again, the solution was vortexed, sonicated, and centrifuged. The cell suspension
was loaded with Fluo-4 AM at a total concentration of 1 μM. Cells were left in the dark at
room temperature for 20 min; then cells were centrifuged for 2 minutes at 200 rpm. The cell
pellet was resuspended in an indicator-free Tyrode solution from Sigma Aldrich (MO, US).
The solution was left for 20 minutes to allow for the complete de-esterification of AM esters.
Within two hours, Ca2+ imaging was performed using the Olympus IX83 confocal microscope
(Olympus Scientific Solutions Americas Inc., MA, US) and cellSens software. Images were
acquired at 20x magnification (NA 0.45) air and (438.6 μm × 330.24 μm) resolution through
consecutive scans of Brightfield, Fluo-4 AM (excitation 488 nm), and AF 568 (excitation 561
nm) at the fastest setting (~12 frames/minute) for 10 minutes. The Ca2+ flux was measured
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mean intensity of Fluo-4AM value. The control samples were NT, CD19.CAR-T cells and
GD2.CAR-T cells on ICAM-1 surface.
Statistical analyses
Statistical analysis was performed using GraphPad PRISM 8 (CA, USA). Data were repre-
sented as mean ± standard deviation (SD) and analyzed using Welch ANOVA with α = 0.05.
Games-Howell post hoc tests were used to compare individual groups with statistical signifi-
cance accepted at p< 0.05.
Results and discussion
Fabrication of antigen-presenting cell surfaces
Antigen-presenting cell surfaces were fabricated using microcontact printing. Glass substrates
were micropatterned with Abs using PDMS stamps, as shown in Fig 1. Printed micropatterns
were fluorescently-labeled post pattern transfer rather than printing pre-labeled micropatterns
to ensure that the Ab binding site is not blocked [12, 13]. In order to ensure consistent contact
between the cells and the antigen-presenting cell surfaces, the surface density of the patterned
micropatterns was inspected for uniformity [11, 13, 18]. The fluorescence intensity of the
micropatterns correlated linearly with the concentration of the labeling Ab (S1 File), suggest-
ing that a higher fluorescence intensity indicates a higher surface concentration of the micro-
patterns. Coverslips patterned with anti-CD3 Ab micropatterns was imaged using the ZEISS
LSM 710 two-photon confocal microscope (Carl Zeiss Microscopy, LLC, NY, US) and ana-
lyzed with ImageJ (NIH, US). The surface density of the micropatterns was inspected by a plot
profile of the fluorescence intensity of anti-CD3 Ab micropatterns (50 μg/mL) labeled with
568 Rabbit Anti-Goat IgG (2 μg/mL). The profile showed equal intensity peaks, indicating a
uniform surface density of micropatterns, see Fig 2.
Fig 1. Schematic of steps of microcontact printing. (A) PDMS stamp with an array of posts as a pattern, (B) Incubation of the protein ink on the
PDMS stamp, (C) Adsorption of the protein ink on the stamp, (D) Bringing the stamp onto contact with the glass coverslip, and (E) Transfer of the
ink to the glass coverslip.
https://doi.org/10.1371/journal.pone.0238819.g001
PLOS ONE Activation and degranulation of CAR-T cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0238819 September 25, 2020 5 / 16
Quantitative analysis of T cell activation
The activation of NT, CD19.CAR-T cells, and GD2.CAR-T cells upon interacting with anti-
gen-presenting cell surfaces was studied. Cells were incubated on substrates coated with
ICAM-1 (control), anti-CD3 Ab (TCR target), and anti-idiotype Ab (CAR target). The trans-
duction efficiencies of CAR-T cells were assessed at day 12–14 of culture, see Fig 3. CD19.
CAR-T cells showed higher transduction efficiency than GD2.CAR-T cells. Higher transduc-
tion efficiency translates to more CAR molecules on the cell surface, meaning that CD19.
CAR-T cells had more CAR molecules than GD2.CAR-T cells. The number of CD19.CAR-T
Fig 2. Intensity profile of anti-CD3 Ab micropatterns (50 μg/mL) labeled with 568 Rabbit Anti-Goat IgG (2 μg/mL) showing
uniform intensity peaks indicating the uniform surface density of anti-CD3 Ab micropatterns. Scale bar 10 μm.
https://doi.org/10.1371/journal.pone.0238819.g002
Fig 3. Transduction efficiencies for CD19.CAR-T cells and GD2.CAR-T cells represented by Median Fluorescence Intensity (MFI).
Cells were stained with 233-4A (CD19 CAR target) and 1A7 (GD2 CAR target) anti-idiotype Abs followed by incubation with a goat-
anti mouse secondary Ab. Control cells are represented by T cells (NT) following the same procedure of activation and expansion, but
without the vector transduction.
https://doi.org/10.1371/journal.pone.0238819.g003
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cells was normalized to offset the discrepancy in transduction efficiencies. CD19.CAR-T cells
were diluted with NT to normalize the number of CAR-T cells in each population. Normaliza-
tion eliminated the possibility of variation in response solely because of the higher number of
CAR molecules in CD19.CAR-T cells. Upon incubating cells on the antigen-presenting cell
surfaces, cells recognized the micropatterns resulting in activation and degranulation. NT,
CD19.CAR-T cells, and GD2.CAR-T cells were incubated on anti-CD3 Ab micropatterns to
test activation through the native TCR. Furthermore, CD19.CAR-T cells and GD2.CAR-T
cells were incubated with their respective target anti-idiotype Ab (233-4A and 1A7) to monitor
the activation through the CAR. For control samples, cells were incubated on surfaces coated
with ICAM-1 only. The aggregation of p-CD3z at the contact point with micropatterns indi-
cated cell activation through the native TCR and the CAR [23], see Fig 4. The degree of aggre-
gation varied depending on the cell type and the substrate. NT had a high degree of p-CD3z
aggregation. CD19.CAR-T cells and GD2.CAR-T cells also showed some aggregation of p-
Fig 4. Activation and degranulation of NT and CAR-T cells on ICAM-1-coated surface (control) and antigen-
presenting cell surfaces depicted by the aggregation of p-CD3z and CD107a. (A) Bright-field image, (B)
micropatterns (5 μm) labeled with Alexa Fluor 568 Goat anti-mouse secondary Ab, (C) p-CD3z labeled with Alexa
Fluor 488 primary Ab, (D) LAMP1 labeled with Alexa Fluor 405 primary Ab, and (E) image of BCD combined. Scale
bar 20 μm.
https://doi.org/10.1371/journal.pone.0238819.g004
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CD3z when activating through the TCR or the CAR. The aggregation of p-CD3z suggests that
the antigen-presenting cell surfaces successfully activated NT and CAR-T cells upon contact.
The aggregation of p-CD3z was quantified by measuring the intensity of the AF488-labeled
p-CD3z. Levels of activation in NT and CAR-T cells were compared to inspect the reported dif-
ferences in activation between TCR and CAR engagement [8, 9, 12]. The corrected total cell
fluorescence (CTCF) values of p-CD3z labeled with Alexa Fluor 488 for cells on control and tar-
get surfaces are provided in Fig 5. Activation levels of NT and CAR-T cells on ICAM-1-coated
surfaces were similar since ICAM-1 is an adhesion molecule, and both NT and CAR-T cells
interact similarly with adhesion molecules. NT did not show significant activation when treated
with 1A7 Ab micropatterns suggesting that the response to the 1A7 Ab is CAR specific. As
expected, NT and CAR-T cells showed higher levels of p-CD3z when exposed to the anti-CD3
Ab micropatterns because they remain susceptible to activation via their native TCR [5, 7, 10,
12, 13, 24]. However, both CD19.CAR-T cells and GD2.CAR-T cells showed lower levels of p-
CD3z upon activation through the native TCR as compared to NT, suggesting that CAR mole-
cules may partially sequester the endogenous CD3z chains making them less available for the
native TCR. Both CD19.CAR-T cells and GD2.CAR-T cells showed high levels of CTCF as com-
pared to control, upon interacting with their respective anti-idiotype Ab suggesting that micro-
patterns of 233-4A and 1A7 Ab successfully activated the CAR. However, while CD19.CAR-T
cells stimulated through the CAR showed similar levels of activation as NT stimulated via TCR
engagement, GD2.CAR-T cells showed inferior activation via CAR as compared to CD19.
CAR-T cells. CD19.CAR-T cells and GD2.CAR-T cells were normalized for transduction effi-
ciency before testing, but in general, the mean fluorescence intensity (MFI) of CD19 CAR is
higher than GD2 CAR suggesting that more CAR molecules of the CD19 CAR are expressed
even if the transduction efficiency is equal, and thus, activation upon CAR stimulation is supe-
rior. The high degree of CD19 CAR aggregation observed here is consistent with previous stud-
ies showing that CD19 CAR receptor aggregates when engaged to the target [25].
Fig 5. Comparison of p-CD3z levels of NT and CAR-T cells upon engagement with antigen-presenting cell surfaces. (A) Semilog plot of the corrected total
cell fluorescence (CTCF) levels of Alexa Fluor 488-labeled p-CD3z in NT, CD19.CAR-T cells, and GD2.CAR-T cells on ICAM-1-coated surfaces (control) and
micropatterns of anti-CD3 Ab and respective target anti-idiotype Abs. (B) Semilog plot of the comparison of CTCF levels of Alexa Fluor 488-labeled p-CD3z in
NT, CD19.CAR-T cells, and GD2.CAR-T cells on micropatterns on respective target anti-idiotype Ab. Bars refer to the mean of CTCF, and the error bars refer to
the standard deviation; ns not significant, ��� p<0.001 (Welch ANOVA test, α = 0.05). Data for each sample were acquired from at least two fields of view (n>2)
with all imaged cells included in the analysis (n>60). Data were pooled from three independents experiments.
https://doi.org/10.1371/journal.pone.0238819.g005
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Quantitative analysis of T cell degranulation
Degranulation of NT, CD19.CAR-T cells, and GD2.CAR-T cells upon interacting with anti-
gen-presenting cell surfaces was quantified by measuring the intensity of the AF405-labeled
LAMP-1/CD017a to examine the differences in degranulation between TCR and CAR engage-
ment [8, 9, 12]. NT, CD19.CAR-T cells and GD2.CAR-T cells were incubated on anti-CD3 Ab
micropatterns to analyze degranulation when cells are activated through the native TCR.
Besides, CD19.CAR-T cells and GD2.CAR-T cells were incubated with their respective target
anti-idiotype Ab (233-4A and 1A7) to inspect degranulation when cells are activated through
the CAR. Fig 4 shows the expression of CD107a upon the interaction of cells with micropat-
terns. Cells showed different levels of CD107a expression depending on the cell type and the
substrate. Fig 6 shows the corrected total cell fluorescence (CTCF) values of CD107a labeled
with Alexa Fluor 405 for cells on control and target surfaces. NT and CAR-T cells interacting
with ICAM-1-coated surfaces showed lower degranulation levels, as ICAM-1 is an adhesion
molecule and does not induce degranulation independently [26]. NT did not show significant
degranulation when activated with 1A7 Ab micropatterns suggesting that degranulation upon
interacting with the 1A7 Ab is CAR specific. NT and CAR-T cells showed higher degranula-
tion levels when incubated on anti-CD3 Ab micropatterns due to activation via the native
TCR. Similar to the activation study, both CAR-T cells showed lower levels of degranulation
compared to NT upon activating through the native TCR. Degranulation in NT activated with
anti-CD3 Ab micropatterns increased by two-folds compared to control samples. CD19.
CAR-T cells showed a three-fold increase in degranulation when activated by anti-CD3 Ab
micropatterns, while GD2.CAR-T cells showed a one-fold increase. Both CD19.CAR-T cells
and GD2.CAR-T cells upon interacting with their respective anti-idiotype Ab showed three-
folds and one-fold increase in degranulation, respectively. The increase in degranulation sug-
gests that micropatterns of 233-4A and 1A7 Ab successfully induced degranulation via the
CAR. CD19.CAR-T cells showed higher degranulation levels when activated through the
Fig 6. Comparison of CD107a levels of NT and CAR-T cells upon engagement with antigen-presenting cell surfaces. (A) Semilog plot of the corrected total
cell fluorescence (CTCF) of Alexa Fluor 405-labeled LAMP1 in NT, CD19 and GD2 CAR-T cells on ICAM-1-coated surfaces (control) and micropatterns of anti-
CD3 Ab and respective target anti-idiotype Abs, (B) Semilog plot of the comparison of CTCF of Alexa Fluor 405-labeled CD107a in NT, CD19, and GD2 CAR-T
cells on surfaces micropatterned with respective target antigens, the bar refers to the mean of CTCF and the error bar refer to the standard deviation, ns not
significant, �� p<0.02, ��� p<0.001 (Welch ANOVA test, α = 0.05). Data were pooled from three experiments. Data for each sample was acquired from at least
two field of views (n>2) with all imaged cells included in the analysis (n>60).
https://doi.org/10.1371/journal.pone.0238819.g006
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native TCR as compared to being activated through the CAR. Previous studies have already
shown that CD19.CAR-T cells experience higher stimulation when stimulated through the
TCR [27]. On the other hand, GD2.CAR-T cells showed similar levels of degranulation,
whether stimulated through the TCR or the CAR.
The profiles of p-CD3z and CD107a levels (Figs 5B and 6B) of NT stimulated through the
TCR and CD19/GD2.CAR-T cells stimulated through the CAR are similar. For both markers,
the response of NT stimulated through the native TCR was higher than CAR-T cells. The
higher level for both markers in NT could be attributed to the longer synapse duration in NT
compared to the shorter synapse duration in CAR-T cells [7, 10, 24, 28].
Morphology of cells interacting with antigen-presenting cell surfaces
The morphology and size of NT, CD19.CAR-T cells, and GD2.CAR-T cells were inspected to
investigate whether different Ab micropatterns induced changes in cell morphology. In gen-
eral, NT and CAR-T cells did not show a significant change in size after interacting with their
respective target antigen-presenting cell surface. All cells had an average size of approximately
2.5 μm. Cell morphology was quantified using the circularity measurement in ImageJ. As
shown in Fig 7, the morphology of NT and GD2.CAR-T cells did not change when interacting
with either control or target surfaces. Both cell types exhibited an average circularity of 0.9.
The circular morphology indicates that NT and GD2.CAR-T cells adhered to the surface after
interacting with micropatterns [29]. The adhesion suggests that both NT and GD2.CAR-T
cells recognized the substrate (anti-CD3 Ab and 1A7 anti-idiotype Ab) and interacted with it.
On the contrary, CD19.CAR-T cells exhibited elongated morphology (circularity value less
than 0.9), indicating that these cells displayed higher motility while interacting with micropat-
terns of anti-CD3 Ab and 233-4A anti-idiotype Ab [29–33]. The higher motility can be
explained by the short engagement time of CAR-T cells with antigens, as shown in previous
studies [7, 24].
Fig 7. Comparison of size and morphology of NT, CD19.CAR-T cells, and GD2.CAR-T cells upon engagement with antigen-presenting cell
surfaces. (A) Size of NT, CD19.CAR-T cells, and GD2.CAR-T cells on ICAM-1-coated surfaces (control) and micropatterns of anti-CD3 Ab and
respective target anti-idiotype, (B) Cell morphology represented by the circularity of NT, CD19.CAR-T cells, and GD2.CAR-T cells on ICAM-
1-coated surfaces (control) and micropatterns of anti-CD3 Ab and respective target anti-idiotype Abs.
https://doi.org/10.1371/journal.pone.0238819.g007
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Live imaging
To further confirm the activation of cells on the antigen-presenting cell surfaces, live imaging
of single NT and CAR-T cell was conducted. We hypothesized that the antigen-presenting cell
surfaces will activate both NT and CAR-T cells and will induce an increase in the intracellular
Ca2+ flux. The intracellular Ca2+ flux in NT and CAR-T cells upon engagement with the anti-
gen-presenting cell surface was reported by measuring the intensity of the green fluorescence
of the cell-permeable Ca2+ sensitive dye Fluo-4-AM. The interaction of a single NT with anti-
CD3 Ab micropatterns is shown in Fig 8; see S1 Movie. The NT came to a complete stop at
115 s, indicating that the cell is interacting with micropatterns [29]. The NT stopped for 5 sec-
onds and then started moving again. The five seconds stop corresponded to an increase in the
Fig 8. Temporal evolution of Ca2+ flux intensity in NT cell engaging anti-CD3 Ab micropatterns accompanied by
profiles of Ca2+ flux intensity and cell velocity. Scale bar 20 μm.
https://doi.org/10.1371/journal.pone.0238819.g008
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Ca2+ flux indicated by the increase in intensity. The NT stopped several times to interact with
the pattern. Every stop correlated with an increase in Ca2+ flux.
The interaction of a single CD19.CAR-T cell with 233-4A micropatterns is shown in Fig 9;
see S2 Movie. The CD19.CAR-T cell came to a complete stop at 55 s. The complete stop corre-
sponded to an increase in Ca2+ intensity, indicating that the CD19.CAR-T cell has recognized
the micropattern. In the period between 130 and 160 s, the cell was precisely on top of the
micropattern, and the intensity started increasing, reaching a maximum at 190 s.
The GD2.CAR-T cell recognizing the 1A7 micropatterns demonstrated by the rapid
increase in Ca2+ intensity, reaching a maximum at 130 s, see Fig 10. After that, the intensity
decreased and stabilized. The constant intensity suggests that the cell was still engaged with the
micropattern; see S3 Movie.
Fig 9. Temporal evolution of Ca2+ flux intensity in CD19.CAR-T cell engaging 233-4A Ab micropatterns
accompanied by profiles of Ca2+ flux intensity and cell velocity. Scale bar 20 μm.
https://doi.org/10.1371/journal.pone.0238819.g009
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Looking at the Ca2+ flux in the three cells, the Ca2+ flux was higher for the NT cell than
CD19 and GD2 CAR-T cells. The level of Ca2+ flux in both CAR-T cells was similar. The
higher intensity level of the NT cell is in agreement with our previous results showing higher
levels of p-CD3 z and LAMP1 in NT.
Conclusion
In this study, we presented a systematic method to study activation and degranulation in
CAR-T cells using antigen-presenting cell surfaces. The antigen-presenting cell surfaces suc-
cessfully activated the cells and displayed uniform surface density. The levels of p-CD3z and
CD107a in NT, CD19.CAR-T cells, and GD2.CAR-T cells were quantified. The level of activa-
tion of NT activating through the TCR and CD19.CAR-T cells activating through the CAR
Fig 10. Temporal evolution of Ca2+ flux intensity in GD2.CAR-T cell engaging 1A7 Ab micropatterns
accompanied by profiles of Ca2+ flux intensity and cell velocity. Scale bar 20 μm.
https://doi.org/10.1371/journal.pone.0238819.g010
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was comparable, while GD2.CAR-T cells showed inferior levels of activation through the CAR.
NT activating via the TCR showed higher levels of degranulation than both CAR-T cells acti-
vating through the CAR. The results confirm that antigen-presenting cell surfaces successfully
activated and induced degranulation in NT and CAR-T cells. Single-cell live imaging results
were in agreement with our fixed-cells study showing that NT had a higher intracellular Ca2+
flux indicating higher activation than CAR-T cell. The insights from this study can help in
designing better CAR-T cells and improve CAR-T cell therapy.
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